investor.ironwoodpharma.comIronwood Pharmaceuticals, Inc. - Home

Skip to main content Linkedin Twitter Investors Media Contact Us Our Company Our Product Our Pipeline Partnerships Patients Join Us Search Close Our Company Our Product Our Pipeline Partnerships Patients Join Us Linkedin Twitter Investors Investors IR Home Events & Presentations Corporate Governance Governance Documents Executive Management Board of Directors Committee Composition Contact the Board Financial Information Quarterly Results Annual Reports SEC Filings Key Ratios Stock Information Stock Quote & Chart Historical Stock Quote Analyst Coverage Investor FAQs Press Releases Investor Contacts Investor Emails Alerts RSS Feeds Home › Home Corporate Overview At Ironwood, we're focused on delivering differentiated medicines to patients and generating outstanding returns for shareholders. If we do this efficiently and effectively, we hope to inspire continued support so that we can seek to develop and deliver more medicines for patients living with GI diseases. These are not small goals, but we believe they represent the best way to maximize long-term value for both patients and shareholders. Read More Featured Reports View All Results Featured Events View All Events View All News Recent News Investor Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Ironwood Pharmaceuticals, Inc., we strive to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Ironwood Pharmaceuticals, Inc. to send you the requested Investor Email Alert updates. * Required Email Address * Mailing Lists * News Events & Presentations SEC Filings End of Day Stock Quote Quarterly Reports Annual Reports Enter the code shown above. * Email Alert Sign Up Confirmation Contact Us Meredith Kaya Vice President, Strategy, Investor Relations and Corporate Communications 617.374.5082 Mkaya@ironwoodpharma.com Garret Bonney Manager, Investor Relations and Corporate Strategy 617.374.4841 GBonney@ironwoodpharma.com Auditors Ernst & Young 200 Clarendon Street Boston, MA 02116 617.266.2000 Transfer Agent Computershare Investor Services P.O. Box 30170 College Station, TX 77842 800.662.7232 www.computershare.com Our Company Our Values Our Executive Team Our Board of Directors Open Payments and Transparency Our Product Discovery of Linaclotide Our Pipeline IW-3718 MD-7246 Partnerships Patients Join Us Open Positions HR Policies Investors Events & Presentations Corporate Governance Financial Information Stock Information Investor FAQ Press Releases Investor Contacts Media Contact Us Follow Us Linkedin Twitter Back To Top Button Privacy Policy Terms of Use Site Map Contact Us Copyright © , Ironwood Pharmaceuticals, Inc. All Rights Reserved LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved. Powered By Q4 Inc. 5.28.0.10 (opens in new window)...